PT2.12.02 Effect of JIN-A02, a Novel 4Th-Generation EGFR-TKI, on Multiple EGFR Mutations in Comparison With 3rd-Generation EGFR-TKIs
Back to course
Asset Subtitle
Hee-Yeon Kim
Meta Tag
Speaker Hee-Yeon Kim
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Powered By